Skip to main content
. Author manuscript; available in PMC: 2016 Sep 6.
Published in final edited form as: Cancer Gene Ther. 2016 May 20;23(7):221–228. doi: 10.1038/cgt.2016.21

Figure 7.

Figure 7

Effect of Tmab/Luc complex treatment on cell viability. Charts show XTT viability (upper panel) and luciferase activity (RLU × 105 units/μg protein, lower panel) of Her18 cells at 24 hr, 48 hr, and 72 hr after an initial 3-hour treatment with 90 μl medium plus 10 μl/well of Tmab/Luc complex or with 100 μl medium/well as a control (no complex). BCA protein determinations were done on the same cell extracts used for the luciferase assay. The control cells without any complexes had no detectable luciferase activity above the baseline. The data are shown as the mean +/- S.E. (n = 3).